References
- Kirchner GI, Meier-Wiedenbach I, Manns MP. Clinical pharmacokinetics of everolimus. Clin Pharmacokinet 2004; 43:83–96.
- Mahalati K, Kahan BD. Clinical pharmacokinetics of sirolimus. Clin Pharmacokinet 2001;40:573–85.
- Mabasa VH, Ensom MHH. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther Drug Monit 2005;27:666–76.
- Sallustio BC, Noll BD, Morris RG. Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods. Clin Biochem 2011;44:231–6.
- Salm P, Warnholtz C, Boyd J, Arabshahi L, Marbach P, Taylor JP. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients. Clin Biochem 2006;39:732–8.
- Khoschsorur GA, Fruehwirth F, Zelzer S, Stettin M, Halwachs-Baumann G. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation. Clin Chim Acta 2007;380:217–21.
- Baldelli S, Crippa A, Gabrieli R, Fiocchi R, Perico N, Merlini S, Ottomano C, Cattaneo D. Comparison of the Innofluor® certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation. Clin Biochem 2006;39:1152–9.
- Bouzas L, Tutor JC. Determination of everolimus in whole blood using the Abbott IMx® sirolimus microparticle enzyme immunoassay. Clin Biochem 2007;40:132–6.
- Pieri M, Miraglia N, Gentile A, Polichetti G, Castiglia L, Federico S, Sabattini M, Basile V, Tarantino G, Acampora A, Capone D. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation. Int J Immunopathol Pharmacol 2008;21:585–94.
- Bouzas L, Hermida J, Tutor JC. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor® fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method. Upsala J Med Sci 2009;114: 55–61.
- Vethe NT, Gjerdalen LC, Bergan S. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospary ionization and tandem mass spectrometry: assessment of matrix effects and assay performance. Scand J Clin Lab Invest 2010;70: 583–91.
- Dasgupta A, Moreno V, Balark S, Smith A, Sonilal M, Tejpal N, Van Buren CT. Rapid estimation of whole blood everolimus concentrations using Architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry. J Clin Lab Anal 2011;25:207–11.
- Wilson D, Johnston F, Holt D, Moreton M, Engelmayer J, Gaulier JM, Luthe H, Marquet P, Moscato D, Oellerich M, Mosso R, Streit F, Brunet M, Fillee C, Schmid R, Wallemacq P, Barnes G. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clin Biochem 2006;39:378–86.
- Schmid RW, Lotz J, Schweigert R, Lackner K, Aimo G, Friese J, Rosiere T, Dickson D, Kenney D, Maine GT. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott Architect analyzer. Clin Biochem 2009;42: 1543–8.
- Courtais C, Dupuy AM, Bargnoux AS, Pageaux GP, Fegueux N, Mourad G, Cristol JP. Evaluation of two sirolimus assays using the Architect-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method. Clin Chem Lab Med 2010;48:1523–5.
- Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK. Evaluation of the Abbott Architect i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and established liquid chromatography-tandem mass spectrometry method. Ther Drug Monit 2011;33:453–9.
- Capone D, Gentile A, Polichetti G, Federico S, Sabbatini M, Acampora A, Basile V, Pieri M, Tarantino G. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients. Int J Immunopathol Pharmacol 2008;21: 297–307.
- Eksborg S. Evaluation of method-comparison data. Clin Chem 1981;27:1311–2.
- Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical validation. A revisit with a decade of progress. Pharm Res 2000;17:1551–7.
- Elevitch FR, editor. College of American Pathologists Conference II (1976): Analytical Goals in Clinical Chemistry. College of American Pathologists, Skokie, 1978.